Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Jeffrey Cilley"'
Publikováno v:
Expert Opinion on Biological Therapy. 7:739-749
Bevacizumab is a humanised monoclonal antibody that inhibits vascular endothelial growth factor (VEGF), the key mediator of tumour angiogenesis, and has been shown to improve survival when given with chemotherapy to patients with metastatic colorecta
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::10625b346338f44761020c7f94485866
https://doi.org/10.1517/14712598.7.5.739
https://doi.org/10.1517/14712598.7.5.739
Publikováno v:
Best Practice & Research Clinical Haematology. 19:669-684
High-dose therapy followed by autologous hematopoietic stem-cell transplantation is the preferred therapy for relapsed chemotherapy-sensitive aggressive non-Hodgkin lymphoma, and may play a role in the treatment of high-risk first-remission aggressiv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5f0708de94ced0acdaa5a73447f1fe12
https://doi.org/10.1016/j.beha.2006.05.004
https://doi.org/10.1016/j.beha.2006.05.004
Autor:
Leo I. Gordon, Jayesh Mehta, C Rihn, Martin S. Tallman, Jane N. Winter, Jeffrey Cilley, Seema Singhal, Stephanie F. Williams, Joanne Monreal
Publikováno v:
Bone Marrow Transplantation. 33:161-164
The number of CD34+ cells infused influences hematologic recovery after transplantation. Limited data suggest that cell dose should be based on ideal (IBW) rather than actual (ABW) body weight for autotransplantation, but none in allografts. We compa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::38f4f318429366a7764ca5518d9e945a
https://doi.org/10.1038/sj.bmt.1704388
https://doi.org/10.1038/sj.bmt.1704388
Autor:
Jeffrey Cilley, L. Gallot, Alfred Rademaker, Annette Larson, Daina Variakojis, Jane N. Winter, Rupali Roy, Stewart Spies, David Patton, Andrew M. Evens, Leo I. Gordon
Publikováno v:
Leukemialymphoma. 54(3)
Preclinical studies suggest that bortezomib, through inhibition of nuclear factor-κB (NF-κB) activation, may enhance the effects of radioimmunotherapy. This phase I trial was designed to determine the maximum tolerated dose (MTD) of weekly bortezom
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::147be185d57ca387c79efb755ef2ceda
https://pubmed.ncbi.nlm.nih.gov/22906230
https://pubmed.ncbi.nlm.nih.gov/22906230
Autor:
Jeffrey J. Raizer, Jeffrey Cilley
Publikováno v:
Cancer Neurology In Clinical Practice ISBN: 9781588299833
Neurologic complications are a relatively rare complication of gastrointestinal malignancies. In most cases, the complications that result are from direct spread of the individual tumor types to the affected areas of the central or peripheral nervous
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::40063e857ae2eba2f6cf1ee8c09e3bcb
https://doi.org/10.1007/978-1-59745-412-4_25
https://doi.org/10.1007/978-1-59745-412-4_25
Autor:
Andrew M. Evens, Alfred Rademaker, Connie Augustyniak, Sarah Miyata, Kara Catsaros, Daina Variakojis, Charles L. Bennett, Martin S. Tallman, Nanjiang Hou, Leo I. Gordon, Jane N. Winter, Taylor Ortiz, Jeffrey Cilley, Mrinal M. Gounder
Publikováno v:
British journal of haematology. 137(6)
Dose-intensity of chemotherapy is important in the treatment of Hodgkin lymphoma (HL) and granulocyte-colony stimulating factor (G-CSF) is commonly used to maintain it. We reviewed all newly diagnosed HL patients who were treated at our institution b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b98942ab85913b693410bacc09a43430
https://pubmed.ncbi.nlm.nih.gov/17459049
https://pubmed.ncbi.nlm.nih.gov/17459049
Autor:
Mary F. Mulcahy, Jeffrey Cilley
Publikováno v:
Current oncology reports. 8(3)
Colon cancer is a leading cause of cancer and cancer deaths in Western countries. Although 5-fluorouracil is still the basis of adjuvant therapy, advances in drug development have led to increased efficacy with the addition of oxaliplatin and options
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a07dc32c4e07a58808b030627c815c00
https://pubmed.ncbi.nlm.nih.gov/16618379
https://pubmed.ncbi.nlm.nih.gov/16618379
Autor:
Jeffrey, Cilley, Jane N, Winter
Publikováno v:
Haematologica. 91(1)
Relapse continues to be the primary cause of treatment failure in patients with non-Hodgkin's lymphomas (NHL) undergoing high-dose therapy and autologous stem cell transplantation. The anti-CD20 radioimmunoconjugates, Y-90 ibritumomab tiuxetan (Zeval
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::9690c974a59e2cfd50628dde95fd3de8
https://pubmed.ncbi.nlm.nih.gov/16434379
https://pubmed.ncbi.nlm.nih.gov/16434379
Autor:
Christopher, Rihn, Jeffrey, Cilley, Payal, Naik, Amit Verma Jennifer, Pedicano, Jayesh, Mehta
Publikováno v:
Haematologica. 89(6)
Neutrophil counts continued to rise after reaching 0.5x10(9)/L in 78 allograft recipients receiving granulocyte colony-stimulating factor (G-CSF) post-transplant. This was confirmed in 44 subsequent patients not receiving G-CSF. This suggests that th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::ff00cb035bf41fe165f61f57caaf740b
https://pubmed.ncbi.nlm.nih.gov/15194552
https://pubmed.ncbi.nlm.nih.gov/15194552
Autor:
Daina Variakojis, Jeffrey Cilley, Jane N. Winter, Andrew M. Evens, Alfred Rademaker, Leo I. Gordon, Annette Larsen, Stewart Spies, Rupali Roy, David Patton
Publikováno v:
Blood. 116:1749-1749
Abstract 1749 Background: Preclinical studies suggest that bortezomib, through inhibition of NF-kB activation, may act as a radiosensitizer and enhance the effects of radioimmunotherapy. Methods: This phase I trial was designed to determine the maxim
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bb34ad80376c9fe9f441ce49f13fe1fd
https://doi.org/10.1182/blood.v116.21.1749.1749
https://doi.org/10.1182/blood.v116.21.1749.1749